Physician profile
Steven Long
NPI 1871258889
$647.01
in general payments reported to CMS, 2019-2025
13 companies · $40.66 in 2025
The $40.66 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.78 · 2022: $396 · 2023: $119 · 2024: $33.60 · 2025: $40.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $140.41 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $101.90 | 2023 | |
| Vanda Pharmaceuticals INC. | $92.13 | 2022 | |
| Bausch Health US, LLC | $58.29 | 2022 | |
| Alkermes, INC. | $46.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.38 | 2021-2022 | |
| Boston Scientific Corporation | $40.66 | 2025 | Embold Fibered |
| Axsome Therapeutics, INC. | $33.60 | 2024 | Auvelity |
| Noven Therapeutics, LLC | $30.35 | 2021-2022 | |
| Abbvie INC. | $17.31 | 2023 | |
| Indivior INC. | $15.28 | 2022 | |
| Merck Sharp & Dohme LLC | $13.55 | 2022 | |
| Orexo US, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.